Towards Personalization in the Curative Treatment of Gastric Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Towards Personalization in the Curative Treatment of Gastric Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-30
DOI
10.3389/fonc.2020.614907
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Japanese gastric cancer treatment guidelines 2018 (5th edition)
- (2020) Gastric Cancer
- Positive Status of Epstein-Barr Virus as a Biomarker for Gastric Cancer Immunotherapy
- (2020) Tong Xie et al. JOURNAL OF IMMUNOTHERAPY
- White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
- (2020) Alessandro Leal et al. Nature Communications
- A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015
- (2020) Rosa T. van der Kaaij et al. EUROPEAN JOURNAL OF CANCER
- Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial
- (2020) Astrid E. Slagter et al. EUROPEAN JOURNAL OF CANCER
- Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO.
- (2020) Ralf Dieter Hofheinz et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
- (2020) Kohei Shitara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
- (2020) Jian Yang et al. Cell Death & Disease
- Feasibility of cone beam CT-guided library of plans strategy in pre-operative gastric cancer radiotherapy
- (2020) Margot Bleeker et al. RADIOTHERAPY AND ONCOLOGY
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
- (2020) Kohei Shitara et al. JAMA Oncology
- Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial
- (2019) Kazuhiro Yoshida et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of age and sex on chemotherapy (CTx) efficacy, toxicity and survival in early oesophagogastric (OG) cancer: A pooled analysis of 3265 patients from four large randomised trials (OE02, OE05, MAGIC & ST03).
- (2019) Avani Athauda et al. JOURNAL OF CLINICAL ONCOLOGY
- ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC).
- (2019) Se Hoon Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.
- (2019) Peter S Hall et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery
- (2019) Felipe José Fernández Coimbra et al. ANNALS OF SURGICAL ONCOLOGY
- Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy
- (2019) Alexander P. Stark et al. ANNALS OF SURGICAL ONCOLOGY
- Immune checkpoint inhibitors in the treatment of virus-associated cancers
- (2019) Peipei Gao et al. Journal of Hematology & Oncology
- Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
- (2019) Filippo Pietrantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials
- (2019) Michael Davidson et al. EUROPEAN JOURNAL OF CANCER
- Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer
- (2018) Yoon Young Choi et al. ANNALS OF SURGERY
- Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden
- (2018) Johannes Asplund et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients
- (2018) Toshitaka Morishima et al. JOURNAL OF EPIDEMIOLOGY
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
- (2018) Annemieke Cats et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Current status and future directions of cancer immunotherapy
- (2018) Hongming Zhang et al. Journal of Cancer
- CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
- (2018) Astrid E. Slagter et al. BMC CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma
- (2017) Rosa T. van der Kaaij et al. EUROPEAN JOURNAL OF CANCER
- Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients With Gastric Cancer
- (2017) Naruhiko Ikoma et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery
- (2017) John H. Saunders et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinicopathological factors associated with HER2-positive gastric cancer
- (2017) Hong-Bo Wang et al. MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
- (2017) Yu-ying Lei et al. World Journal of Surgical Oncology
- Mismatch Repair Deficiency, Microsatellite Instability, and Survival
- (2017) Elizabeth C. Smyth et al. JAMA Oncology
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Immunotherapy against cancer-related viruses
- (2016) Haruko Tashiro et al. CELL RESEARCH
- Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
- (2016) Elizabeth C. Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
- (2016) Salah-Eddin Al-Batran et al. LANCET ONCOLOGY
- HER2 testing in gastric cancer: An update
- (2016) Lucas Faria Abrahao-Machado et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
- (2016) Sarah Derks et al. Oncotarget
- The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial
- (2016) Youjin Kim et al. Journal of Gastric Cancer
- Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis
- (2015) Yong-xi Song et al. DISEASE MARKERS
- Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry
- (2015) Anne Schlesinger-Raab et al. Gastric Cancer
- Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
- (2015) Se Hoon Park et al. JOURNAL OF CLINICAL ONCOLOGY
- The Prognostic Significance of Pretreatment Serum CEA Levels in Gastric Cancer: A Meta-Analysis Including 14651 Patients
- (2015) Kai Deng et al. PLoS One
- Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
- (2014) E. Bajetta et al. ANNALS OF ONCOLOGY
- An Updated Meta-Analysis of Randomized Controlled Trial Assessing the Effect of Neoadjuvant Chemotherapy in Advanced Gastric Cancer
- (2014) Bing-Hong Xiong et al. CANCER INVESTIGATION
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Preoperative chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study
- (2014) Anouk K. Trip et al. RADIOTHERAPY AND ONCOLOGY
- The Prognostic Significance of an R1 Resection in Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy
- (2013) Jurriën Stiekema et al. ANNALS OF SURGICAL ONCOLOGY
- Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis
- (2013) M Constanza Camargo et al. GUT
- Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: A meta-analysis
- (2013) Lei Jiang et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China
- (2013) Miao-zhen Qiu et al. Journal of Translational Medicine
- Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery
- (2012) Karen Becker et al. ANNALS OF SURGERY
- Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
- (2012) F. Mueller et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)
- (2012) Salah-Eddin Al-Batran et al. EUROPEAN JOURNAL OF CANCER
- Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
- (2012) Stephen R. Smalley et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas
- (2011) Karen Becker et al. ANNALS OF SURGERY
- Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis
- (2011) M C Camargo et al. BRITISH JOURNAL OF CANCER
- Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
- (2011) Jeeyun Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008
- (2011) Kyung Sook Lee et al. Cancer Research and Treatment
- Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram
- (2010) Vivian E. Strong et al. ANNALS OF SURGERY
- Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: A pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials
- (2010) Jatoi INTERNATIONAL JOURNAL OF ONCOLOGY
- Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
- (2010) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric Cancer
- (2010) Johan L. Dikken et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
- (2010) Ilfet Songun et al. LANCET ONCOLOGY
- Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy
- (2009) E. P. M. Jansen et al. ANNALS OF ONCOLOGY
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic Location
- (2009) Gwen Murphy et al. GASTROENTEROLOGY
- Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
- (2009) Michael Stahl et al. JOURNAL OF CLINICAL ONCOLOGY
- The Japanese Guidelines for Gastric Cancer Screening
- (2008) C. Hamashima et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Screening for gastric cancer in Asia: current evidence and practice
- (2008) Wai K Leung et al. LANCET ONCOLOGY
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started